Distal Access has announced that it has sold the rights to its SPINR platform for peripheral, coronary, and endoscopic use to Merit Medical System’s NRI Limited. The SPINR high-performance guidewire controller is designed to improve guidewire control, torque, and performance. According to a press release, the SPINR Macerator is a simple and cost-effective way to macerate thrombus.
The press release reports that Distal Access announced FDA clearance for the SPINR high-performance guidewire controller to manoeuver guidewires in the coronary and peripheral vasculature during interventional and diagnostic procedures in February this year. SPINR Macerators are under development and not FDA cleared at this time.
